| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.05M | — |
| Operating expense | — | — |
| Net income | -30.36M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TCRX returned -58.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -22.3% |
| 1 year | -58.4% |
| 5 years | -91.3% |
| All-time high | $9.70 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TCRX would be worth today ›No. TScan Therapeutics, Inc. has not paid a dividend in the past 12 months.
TScan Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TCRX.
TScan Therapeutics, Inc. is part of the Healthcare sector.
TScan Therapeutics, Inc. has a market cap of 52.69M USD, based on the latest quote.
